1. Home
  2. VNRX vs CDLX Comparison

VNRX vs CDLX Comparison

Compare VNRX & CDLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$1.34

Market Cap

24.5M

Sector

Health Care

ML Signal

HOLD

Logo Cardlytics Inc.

CDLX

Cardlytics Inc.

HOLD

Current Price

$4.16

Market Cap

26.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
VNRX
CDLX
Founded
N/A
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
24.5M
26.0M
IPO Year
2012
2018

Fundamental Metrics

Financial Performance
Metric
VNRX
CDLX
Price
$1.34
$4.16
Analyst Decision
Strong Buy
Hold
Analyst Count
5
2
Target Price
$1.67
$2.25
AVG Volume (30 Days)
237.1K
68.5K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
38.00
50.13
EPS
N/A
N/A
Revenue
$1,727,384.00
$233,273,000.00
Revenue This Year
$355.66
N/A
Revenue Next Year
$849.08
$8.82
P/E Ratio
N/A
N/A
Revenue Growth
40.04
N/A
52 Week Low
$0.13
$0.55
52 Week High
$3.26
$6.40

Technical Indicators

Market Signals
Indicator
VNRX
CDLX
Relative Strength Index (RSI) 42.43 55.36
Support Level $1.30 $0.78
Resistance Level $1.56 $6.40
Average True Range (ATR) 0.12 0.36
MACD 0.02 -0.25
Stochastic Oscillator 59.68 17.22

Price Performance

Historical Comparison
VNRX
CDLX

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.

About CDLX Cardlytics Inc.

Cardlytics Inc is a commerce media platform that is designed to make commerce smarter and rewarding for everyone. At the core of its commerce media platform is the financial media network that it runs within its partners' digital channels, which includes online and mobile applications (the Cardlytics platform). Additionally, it operates an identity resolution platform that utilizes point-of-sale (POS) data, including product-level purchase data, to enable marketers to perform analytics and targeted loyalty marketing and also measure the impact of their marketing (the Bridg platform). It operates in three segments: the Cardlytics platform in the U.S.; the Cardlytics platform in the U.K.; and the Bridg platform. The majority of the revenue is derived from the Cardlytics platform.

Share on Social Networks: